Physician profile
Mark D Russell
NPI 1528054269
$1,105.38
in general payments reported to CMS, 2019-2025
11 companies · $54.43 in 2025
The $54.43 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $191 · 2021: $171 · 2022: $313 · 2023: $76.30 · 2024: $110 · 2025: $54.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $831.47 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Pico 7, Aetos Shoulder System |
| Djo, LLC | $103.31 | 2024 | Donjoy, Aircast |
| Orthofix Medical, INC. | $25.13 | 2019-2020 | |
| Biopro, INC. | $23.89 | 2020 | |
| Heraeus Medical, LLC. | $21.18 | 2022-2024 | |
| Stryker Corporation | $19.56 | 2022 | |
| Bioventus LLC | $19.34 | 2020 | |
| Next Science LLC | $18.32 | 2021 | |
| Spinesmith Holdings, LLC | $15.30 | 2019 | |
| Avanos Medical | $14.76 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.12 | 2023 | Zilretta, Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.